Search Within

Sherry Shen

Formats
  1. Meeting Abstract (16)
  2. Journal Article (7)
  3. Review (4)
Groups
  1. GME, Medicine (27)
  2. Graduate Medical Education (27)
  3. Hematology-Oncology Fellows (27)
  4. Department of Medicine (26)
  5. Solid Tumor Oncology Division (26)
  6. Breast Medicine Service (22)

More Groups

People
  1. Neil Iyengar (14)
  2. Yuan Chen (12)
  3. Komal Jhaveri (8)
  4. Mark Robson (7)
  5. Pedram Razavi (6)
  6. Anton Safonov (5)

More People

Years
  1. 2025 (6)
  2. 2024 (7)
  3. 2023 (6)
  4. 2022 (7)
  5. 2021 (1)
Publications
  1. Journal of Clinical Oncology (15)
  2. npj Breast Cancer (2)
  3. Cancer (1)
  4. Cancer Treatment Reviews (1)
  5. Current Breast Cancer Reports (1)
  6. Future Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (15)
  2. Elsevier Inc. (2)
  3. Nature Publishing Group (2)
  4. Elsevier B.V. (1)
  5. Future Medicine (1)
  6. Lippincott Williams & Wilkins (1)

More Publishers

Results (27)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Invasive lobular carcinoma: Strategies and perspectives from the lobular breast cancer research group
    Review

    Corso, G.; Shen, S.; Criscitiello, C.; Mukhtar, R.; Gamble, L.; Rocco, E. G.; Pesapane, F.; Nicosia, L.; Jhaveri, K.; Salimbeni, B. T.; more...
    Cancer Treatment Reviews (2025)

    Fulltext@MSK | Save
  • Timing of neoadjuvant pembrolizumab infusion and pathologic complete response among patients with triple-negative breast cancer receiving the KEYNOTE-522 regimen
    Meeting Abstract

    Shen, S.; Myers, S.; Polidorio, N.; Bromberg, M.; Chen, Y.; Tan, R.; Mai, N.; Abuhadra, N.; Traina, T. A.; Downs-Canner, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Treatment patterns, genomic characteristics, and outcomes among patients with metastatic lobular breast cancer
    Meeting Abstract

    Shen, S.; Pareja, F.; White, C.; Chen, Y.; Safonov, A.; Razavi, P.; Dang, C. T.; Jhaveri, K. L.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Effect of ERBB2 activating mutations on enhanced internalization and activity of trastuzumab deruxtecan in HER2-non-amplified metastatic breast cancer
    Meeting Abstract

    Mai, N.; Liu, B.; Safonov, A.; Shen, S.; Zelizer, S.; White, C.; Chen, Y.; Razavi, P.; Jhaveri, K. L.; Modi, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Treatment patterns in HR+/HER2-metastatic breast cancer (MBC) with co-occurring PIK3CA and ESR1 mutations
    Meeting Abstract

    Teysir, J.; Shen, S.; White, C.; Chen, Y.; Razavi, P.; Jhaveri, K. L.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • ELAINE 3: Phase 3 study of lasofoxifene plus abemaciclib to treat ER+/HER2-, ESR1-mutated, metastatic breast cancer
    Journal Article

    Goetz, M. P.; Wander, S. A.; Bachelot, T.; de Nonneville, A.; Gal-Yam, E. N.; Sammons, S. L.; Shen, S.; Twelves, C.; Boruta, G.; Portman, D. J.; more...
    Future Oncology (2025)

    Fulltext@MSK | Save
  • Real-world (RW) risk of recurrence among patients (pts) diagnosed with stage II-III HR+/HER2-early breast cancer (EBC) treated with endocrine therapy (ET) in the US
    Meeting Abstract

    Razavi, P.; Ahmed, M.; Roush, A.; Parikh, R.; Hitchens, A.; Shen, S.; Safonov, A.; Jhaveri, K. L.; Robson, M. E.; Peacock, N. W.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Glucagon-like peptide-1 (GLP-1) agonist use and weight change among patients with breast cancer
    Meeting Abstract

    Shen, S.; Liu, B.; Fanti, C.; Bromberg, M.; Chen, Y.; Chang, C.; Iyengar, N. M.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Overall survival analysis of first line CDK4/6 inhibitors in a large real-world cohort of patients with hormone receptor-positive (HR+)/HER2-negative metastatic breast cancer
    Meeting Abstract

    Ferraro, E.; Moiso, E.; Safonov, A.; Cabel, L.; Loudon, L.; Dang, C. T.; Shen, S.; Jhaveri, K. L.; Robson, M. E.; Chandarlapaty, S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Sequential use of PI3K/AKT/mTOR pathway inhibitors alpelisib and everolimus in patients with hormone receptor-positive (HR+) metastatic breast cancer
    Meeting Abstract

    Shen, S.; Safonov, A.; Bromberg, M.; Chen, Y.; Ahmed, M.; Razavi, P.; Jhaveri, K. L.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save